| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Nov 19, 2025 | TENAX THERAPEUTICS, INC. | CFO | Buy | 95.0 | +8,000 | 100.00% | ✗ | $58.2K |
| May 24, 2012 | May 25, 2012 | GALECTIN THERAPEUTICS INC | CFO | Buy | 91.3 | +10,000 | 100.00% | ✗ | $23.5K |